{
  "success": true,
  "pagesUsed": [
    2,
    4,
    10,
    12,
    15,
    17,
    20,
    25,
    27,
    29,
    32,
    37,
    39,
    40,
    41,
    42,
    57
  ],
  "modelUsed": "claude-opus-4-5",
  "confidence": 1.0,
  "scheduling": {
    "timings": [
      {
        "id": "timing_1",
        "name": "Run-in Period Diet Equilibration",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "value": 3,
        "relativeTo": "First Dose",
        "windowLower": -7,
        "windowUpper": -5
      },
      {
        "id": "timing_2",
        "name": "Pretreatment Copper Balance Measurement",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "value": 4,
        "relativeTo": "First Dose",
        "windowLower": -4,
        "windowUpper": -1
      },
      {
        "id": "timing_3",
        "name": "Treatment Period 1 - 15 mg/day",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 28,
        "relativeTo": "First Dose",
        "windowLower": 1,
        "windowUpper": 28
      },
      {
        "id": "timing_4",
        "name": "Dose Titration to 30 mg/day",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 29,
        "relativeTo": "First Dose",
        "windowLower": 0,
        "windowUpper": 0
      },
      {
        "id": "timing_5",
        "name": "Inpatient Period 1 Admission",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": -8,
        "relativeTo": "First Dose",
        "windowLower": 0,
        "windowUpper": 0
      },
      {
        "id": "timing_6",
        "name": "Inpatient Period 1 Discharge",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 9,
        "relativeTo": "First Dose",
        "windowLower": 0,
        "windowUpper": 0
      },
      {
        "id": "timing_7",
        "name": "Outpatient Period Return",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "value": 1,
        "relativeTo": "First Dose",
        "windowLower": 22,
        "windowUpper": 23
      },
      {
        "id": "timing_8",
        "name": "Outpatient Period Extension",
        "type": "Within",
        "unit": "days",
        "instanceType": "Timing",
        "value": 14,
        "relativeTo": "Previous Visit",
        "windowLower": 0,
        "windowUpper": 14
      },
      {
        "id": "timing_9",
        "name": "Inpatient Period 2 Duration",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "value": 18,
        "relativeTo": "First Dose",
        "windowLower": 23,
        "windowUpper": 40
      },
      {
        "id": "timing_10",
        "name": "End of Study Visit",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 54,
        "relativeTo": "First Dose",
        "windowLower": -2,
        "windowUpper": 2
      },
      {
        "id": "timing_11",
        "name": "Baseline I/O Collection Period",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "value": 4,
        "relativeTo": "First Dose",
        "windowLower": -4,
        "windowUpper": -1
      },
      {
        "id": "timing_12",
        "name": "Initial 15 mg I/O Collection Period",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "value": 8,
        "relativeTo": "First Dose",
        "windowLower": 1,
        "windowUpper": 8
      },
      {
        "id": "timing_13",
        "name": "Second I/O Collection Period",
        "type": "Between",
        "unit": "days",
        "instanceType": "Timing",
        "value": 15,
        "relativeTo": "First Dose",
        "windowLower": 25,
        "windowUpper": 39
      },
      {
        "id": "timing_14",
        "name": "Steady State Achievement",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 10,
        "relativeTo": "First Dose",
        "windowLower": 0,
        "windowUpper": 0
      },
      {
        "id": "timing_15",
        "name": "Zinc Discontinuation Washout",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 21,
        "relativeTo": "First Dose",
        "windowLower": -21,
        "windowUpper": 0
      },
      {
        "id": "timing_16",
        "name": "Previous Tetrathiomolybdate Washout",
        "type": "Before",
        "unit": "years",
        "instanceType": "Timing",
        "value": 1,
        "relativeTo": "First Dose",
        "windowLower": -365,
        "windowUpper": 0
      },
      {
        "id": "timing_17",
        "name": "Prescription Medication Washout",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 14,
        "relativeTo": "Study Start",
        "windowLower": -14,
        "windowUpper": 0
      },
      {
        "id": "timing_18",
        "name": "Non-prescription Medication Washout",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 7,
        "relativeTo": "Study Start",
        "windowLower": -7,
        "windowUpper": 0
      },
      {
        "id": "timing_19",
        "name": "Alcohol Abstinence Before Dosing",
        "type": "Before",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 48,
        "relativeTo": "First Dose",
        "windowLower": -2,
        "windowUpper": 0
      },
      {
        "id": "timing_20",
        "name": "Overnight Fast Before Dosing",
        "type": "Before",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 10,
        "relativeTo": "First Dose",
        "windowLower": 0,
        "windowUpper": 0
      },
      {
        "id": "timing_21",
        "name": "Post-dose Meal Delay",
        "type": "After",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 2,
        "relativeTo": "First Dose",
        "windowLower": 2
      },
      {
        "id": "timing_22",
        "name": "Outpatient Dosing Window",
        "type": "At",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 1,
        "relativeTo": "Previous Visit",
        "windowLower": -1,
        "windowUpper": 1
      },
      {
        "id": "timing_23",
        "name": "Catheter Maximum Duration",
        "type": "Within",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 72,
        "relativeTo": "Previous Visit",
        "windowLower": 0,
        "windowUpper": 72
      },
      {
        "id": "timing_24",
        "name": "Catheter Flush Interval",
        "type": "Within",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 8,
        "relativeTo": "Previous Visit",
        "windowLower": 0,
        "windowUpper": 8
      },
      {
        "id": "timing_25",
        "name": "Urine Pregnancy Test Interval",
        "type": "Within",
        "unit": "weeks",
        "instanceType": "Timing",
        "value": 4,
        "relativeTo": "Previous Visit",
        "windowLower": 0,
        "windowUpper": 28
      },
      {
        "id": "timing_26",
        "name": "24-hour Urine Collection Void Window",
        "type": "Within",
        "unit": "hours",
        "instanceType": "Timing",
        "value": 2,
        "relativeTo": "Previous Visit",
        "windowLower": 0,
        "windowUpper": 2
      },
      {
        "id": "timing_27",
        "name": "SRC Safety Data Review Timing",
        "type": "At",
        "unit": "days",
        "instanceType": "Timing",
        "value": 23,
        "relativeTo": "First Dose",
        "windowLower": 0,
        "windowUpper": 0
      },
      {
        "id": "timing_28",
        "name": "Experimental Therapy Washout",
        "type": "Before",
        "unit": "days",
        "instanceType": "Timing",
        "value": 90,
        "relativeTo": "Screening",
        "windowLower": -90,
        "windowUpper": 0
      }
    ],
    "conditions": [
      {
        "id": "cond_1",
        "name": "ALT Elevation Criteria",
        "instanceType": "Condition",
        "description": "Criteria for ALT-based dose modification",
        "text": "ALT > 3 × ULN accompanied by bilirubin > 2 × ULN indicative of liver injury"
      },
      {
        "id": "cond_2",
        "name": "Hemoglobin Decrease Criteria",
        "instanceType": "Condition",
        "description": "Criteria for hemoglobin-based dose modification",
        "text": "Hemoglobin > 20% decrease from baseline"
      },
      {
        "id": "cond_3",
        "name": "Platelet Decrease Criteria",
        "instanceType": "Condition",
        "description": "Criteria for platelet-based dose modification",
        "text": "Platelets > 30% decrease from baseline"
      },
      {
        "id": "cond_4",
        "name": "Neutrophil Decrease Criteria",
        "instanceType": "Condition",
        "description": "Criteria for neutrophil-based dose modification",
        "text": "Neutrophils > 30% decrease from baseline"
      },
      {
        "id": "cond_5",
        "name": "Neurological Worsening Criteria",
        "instanceType": "Condition",
        "description": "Evidence of neurologic worsening",
        "text": "Evidence of neurologic worsening by AEs or by neurologic physical exam assessment"
      },
      {
        "id": "cond_6",
        "name": "Psychiatric Worsening Criteria",
        "instanceType": "Condition",
        "description": "Evidence of psychiatric worsening",
        "text": "Evidence of clinically significant acute psychiatric worsening which may include but not limited to suicidality, acute depression, or psychosis"
      },
      {
        "id": "cond_7",
        "name": "SRC Safety Review Approval",
        "instanceType": "Condition",
        "description": "Safety Review Committee approval for dose titration",
        "text": "Before titration to 30 mg/day, the Safety Review Committee will review available safety data through Day 23 for each participant"
      },
      {
        "id": "cond_8",
        "name": "Renal Function Exclusion",
        "instanceType": "Condition",
        "description": "Renal failure exclusion criteria",
        "text": "Participants in renal failure, defined as end-stage renal disease on dialysis (CKD stage 5) or creatinine clearance < 30 mL/min"
      },
      {
        "id": "cond_9",
        "name": "QTcF Change Criteria",
        "instanceType": "Condition",
        "description": "Clinically significant ECG finding",
        "text": "Clinically significant finding including changes from baseline in QT interval corrected using Fridericia's formula"
      }
    ],
    "conditionAssignments": [],
    "transitionRules": [
      {
        "id": "trans_1",
        "name": "Run-in to Treatment Period 1 Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_runin",
        "toElementId": "epoch_treatment1",
        "text": "Following the Run-in Period, participants will be administered ALXN1840 at 15 mg/day"
      },
      {
        "id": "trans_2",
        "name": "Treatment Period 1 to Outpatient Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_treatment1",
        "toElementId": "epoch_outpatient",
        "text": "Participants may be discharged from the CRU on Day 9 to return on Day 22 or Day 23"
      },
      {
        "id": "trans_3",
        "name": "Outpatient to Treatment Period 2 Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_outpatient",
        "toElementId": "epoch_treatment2",
        "text": "Participants will be re-admitted on Day 22 or Day 23 for Treatment Period 2"
      },
      {
        "id": "trans_4",
        "name": "Dose Titration 15 mg to 30 mg",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "fromElementId": "dose_15mg",
        "toElementId": "dose_30mg",
        "text": "Participants will be administered ALXN1840 at 15 mg/day on Day 1 through Day 28 and then increase to 30 mg/day on Day 29"
      },
      {
        "id": "trans_5",
        "name": "ALT Elevation Dose Reduction",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "ALT > 3 × ULN: Reduce dose to previous dose level if up-titration has occurred or reduce dose to 15 mg QOD if on 15 mg QD"
      },
      {
        "id": "trans_6",
        "name": "Hemoglobin Decrease Dose Reduction",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Hemoglobin > 20% decrease from baseline: Reduce dose to previous dose level or reduce to 15 mg QOD if on 15 mg QD"
      },
      {
        "id": "trans_7",
        "name": "Platelet Decrease Dose Reduction",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Platelets > 30% decrease from baseline: Reduce dose to previous dose level or reduce to 15 mg QOD if on 15 mg QD"
      },
      {
        "id": "trans_8",
        "name": "Neutrophil Decrease Dose Reduction",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Neutrophils > 30% decrease from baseline: Reduce dose to previous dose level or reduce to 15 mg QOD if on 15 mg QD"
      },
      {
        "id": "trans_9",
        "name": "Bilirubin Elevation Temporary Interruption",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Bilirubin > 2 × ULN accompanied by ALT > 3 × ULN: Temporary interruption with weekly repeat testing"
      },
      {
        "id": "trans_10",
        "name": "Neurological Worsening Dose Evaluation",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Evidence of neurologic worsening: Investigator and Medical Monitor will evaluate need for dose modification based on copper control parameters"
      },
      {
        "id": "trans_11",
        "name": "Psychiatric Worsening Dose Evaluation",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Evidence of psychiatric worsening: Investigator and Medical Monitor will evaluate need for dose modification based on copper control parameters"
      },
      {
        "id": "trans_12",
        "name": "Rechallenge After Dose Interruption",
        "instanceType": "TransitionRule",
        "transitionType": "Dose Modification",
        "text": "Rechallenge at 15 mg QOD or less frequent when parameters return to baseline. Maximum of 3 rechallenges allowed"
      },
      {
        "id": "trans_13",
        "name": "Serious Hypersensitivity Discontinuation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if serious hypersensitivity reaction occurs"
      },
      {
        "id": "trans_14",
        "name": "Severe Infection Discontinuation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if severe uncontrolled infection occurs"
      },
      {
        "id": "trans_15",
        "name": "Disallowed Medication Discontinuation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if use of disallowed medication occurs"
      },
      {
        "id": "trans_16",
        "name": "Pregnancy Discontinuation",
        "instanceType": "TransitionRule",
        "transitionType": "Discontinuation",
        "text": "Participants must be considered for discontinuation from study intervention if pregnancy or planned pregnancy occurs"
      },
      {
        "id": "trans_17",
        "name": "Post-Study Therapy Transition",
        "instanceType": "TransitionRule",
        "transitionType": "Epoch Transition",
        "fromElementId": "epoch_treatment2",
        "toElementId": "epoch_followup",
        "text": "Following completion of both inpatient periods, participants will transition to previous therapy, other standard of care, or request continuation of ALXN1840"
      }
    ],
    "scheduleTimelineExits": [
      {
        "id": "exit_1",
        "name": "Participant Voluntary Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "A participant may withdraw from the study at any time at his/her own request"
      },
      {
        "id": "exit_2",
        "name": "Investigator Withdrawal",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participant may be withdrawn at any time at the discretion of the Investigator for safety, behavioral, compliance, or administrative reasons"
      },
      {
        "id": "exit_3",
        "name": "Study Completion",
        "exitType": "Completion",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participant has completed all phases of the study including the last scheduled procedure shown in the Schedule of Activities"
      },
      {
        "id": "exit_4",
        "name": "Lost to Follow-up",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Participant repeatedly fails to return for scheduled visits and is unable to be contacted by the study site after 3 telephone calls and certified letter"
      },
      {
        "id": "exit_5",
        "name": "Study Intervention Discontinuation",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "If study intervention is definitively discontinued, participant should remain in study for safety follow-up"
      },
      {
        "id": "exit_6",
        "name": "Site Closure",
        "exitType": "Early Termination",
        "instanceType": "ScheduleTimelineExit",
        "description": "Alexion reserves the right to close the study site or terminate the study at any time"
      }
    ],
    "scheduledDecisionInstances": [
      {
        "id": "dec_1",
        "name": "SRC Dose Titration Decision",
        "timepointId": "day_23",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Safety Review Committee reviews available safety data through Day 23 before titration to 30 mg/day",
        "conditionIds": [
          "cond_7"
        ]
      },
      {
        "id": "dec_2",
        "name": "Outpatient Period Extension Decision",
        "timepointId": "day_9",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Investigator approval required to extend Outpatient Period up to additional 14 days"
      },
      {
        "id": "dec_3",
        "name": "CRU Retention Decision",
        "timepointId": "day_9",
        "instanceType": "ScheduledDecisionInstance",
        "description": "At CRU's discretion, participants may remain in CRU during outpatient period for safety or study integrity"
      },
      {
        "id": "dec_4",
        "name": "Dose Modification Decision",
        "timepointId": "ongoing",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Investigator and Medical Monitor evaluate need for dose modification based on safety parameters",
        "conditionIds": [
          "cond_1",
          "cond_2",
          "cond_3",
          "cond_4",
          "cond_5",
          "cond_6"
        ]
      },
      {
        "id": "dec_5",
        "name": "Rechallenge Decision",
        "timepointId": "post_interruption",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Investigator in consultation with Medical Monitor may change dose and frequency for rechallenge"
      },
      {
        "id": "dec_6",
        "name": "Post-Study Therapy Decision",
        "timepointId": "day_40",
        "instanceType": "ScheduledDecisionInstance",
        "description": "Treating physician determines transition to previous therapy, standard of care, or ALXN1840 continuation"
      }
    ],
    "summary": {
      "timingCount": 28,
      "conditionCount": 9,
      "transitionRuleCount": 17,
      "exitCount": 6
    }
  }
}